Outcome
    Preliminary

    TUDCA for Bile Flow Enhancement

    Tauroursodeoxycholic acid improves bile flow and liver enzymes in cholestasis; its use in healthy people for digestion is unsupported.

    Overview

    TUDCA is the taurine conjugate of ursodeoxycholic acid, a bile acid used clinically for decades in cholestatic liver disease. The supplement market has adopted it largely for liver support, which is a broader claim than the clinical record supports.
    On bile flow specifically the pharmacology is sound: hydrophilic bile acids shift the composition of the bile acid pool and stimulate biliary secretion. The linked evidence, however, is a Cochrane review of bile acids after liver transplantation that found no benefit on mortality or graft loss, which is a very different question.

    Verdict

    Likely effective

    Bile acid pharmacology supports a choleretic effect, and ursodeoxycholic acid is established clinically in cholestasis. The linked Cochrane review addressed post-transplant outcomes and found no effect on mortality or graft loss.

    How It Works

    Bile flow depends on the osmotic pull created by bile acids secreted into the canaliculus. TUDCA is more hydrophilic than the endogenous bile acids it displaces, so it increases bile-acid-dependent flow while reducing the detergent injury that hydrophobic acids inflict on hepatocyte membranes.
    It also stimulates insertion of transporter proteins into the canalicular membrane and reduces endoplasmic reticulum stress in hepatocytes. These effects underpin its clinical use in cholestasis; they are mechanism, not evidence of benefit in people with healthy livers.

    Dosing & Protocol

    Clinical ursodeoxycholic acid dosing runs 13 to 15 mg per kilogram daily. TUDCA supplements typically supply 250 to 1500 mg daily, and the studies that exist in liver disease cluster in the 500 to 1750 mg range. No dose has been validated for bile flow in a healthy person.
    ScenarioDoseFormNotes
    Common supplement dose250 to 500 mg dailyCapsuleTypical label direction
    Range used in liver disease studies500 to 1750 mg dailyCapsule, dividedUnder medical supervision
    Clinical UDCA equivalent13 to 15 mg/kg dailyPrescriptionPrescribed, not supplemental
    Established dose for healthy usersNot established-No validated bile-flow dose exists
    1. 1

      Establish why you are taking it· Before starting

      Cholestasis, gallstones and elevated liver enzymes are medical situations that deserve a diagnosis before a supplement.

    2. 2

      Start at 250 to 500 mg daily with food· Weeks 1 to 4

      Bile acids are secreted in response to meals, so meal timing is the sensible pairing.

    3. 3

      Split larger doses· If escalating

      Doses above 500 mg are usually divided across the day in the studies that used them.

    4. 4

      Monitor liver enzymes if using long term· Every 3 months

      If you are taking it for a liver reason, the enzymes are the endpoint, and they need checking rather than guessing.

    5. 5

      Stop if you develop right upper abdominal pain· Immediately

      Biliary pain warrants assessment, not dose adjustment.

    Evidence

    One source is linked to this pairing: a 2010 Cochrane review of bile acids for liver-transplanted patients. It found no significant effect on mortality or graft loss. That is an important negative result, though it addresses transplant outcomes rather than bile flow in healthy people.
    Best linked evidence
    Cochrane systematic review, liver transplant recipients
    Linked result
    No significant effect on mortality or graft loss
    Relevance to this outcome
    Indirect; the review did not measure bile flow as an endpoint
    Main limitation
    Population and endpoints differ from supplemental use
    Certainty
    Low for bile flow benefit in healthy users

    Studies linked to this pairing.

    Bile acids for liver-transplanted patients

    Score: 8/10
    2010
    systematic_review

    Bile acid therapy after liver transplantation showed no significant effect on mortality or graft loss.

    View source

    Safety

    TUDCA is generally well tolerated, and diarrhoea is the dose-limiting effect for most people, which is unsurprising for a bile acid. The important safety point is anatomical: increasing bile flow against an obstruction is harmful.

    Reported effects

    Diarrhoea, dose related
    Nausea
    Abdominal discomfort
    Contraindicated in biliary obstruction
    Limited long-term supplement data

    Do not use with a suspected bile duct obstruction

    Stimulating bile secretion when the duct is blocked raises pressure in the biliary tree. Obstructive jaundice, biliary colic or a known stone in the duct require medical assessment first.

    Interactions & Conflicts

    Bile acids alter the absorption of anything that depends on bile or binds to it in the gut. Most of the practical interactions come down to separating doses in time.
    Interacts withSeverityMechanismAction
    Bile acid sequestrants such as colestyramine
    high
    		Binds TUDCA and prevents absorptionSeparate by at least four hours
    Aluminium-containing antacids
    moderate
    		Adsorb bile acids in the gutSeparate doses
    Ciclosporin
    moderate
    		Bile acids alter absorption of the drugMonitor drug levels
    Oestrogens and oral contraceptives
    low
    		Increase biliary cholesterol and may oppose the effectNo action; be aware
    Fat-soluble vitamins
    low
    		Altered bile composition changes absorptionTake with meals as usual

    References

    The linked Cochrane review is the only source attached to this pairing, and it is a negative result in a different population. The mechanistic account of choleresis reflects established bile acid physiology and clinical use of ursodeoxycholic acid.
    1. Chen W, Gluud C. Bile acids for liver-transplanted patients. Cochrane Database Syst Rev. 2010

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.